![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print January 19, 2005
Department of Cell Biology, Harvard Medical School, Boston, MA 02115
Corresponding Author: jblenis{at}hms.harvard.edu
The mammalian target of rapamycin, mTOR, is a Ser/Thr kinase that promotes cell growth and proliferation by activating ribosomal protein S6 kinase 1 (S6K1). We previously identified a conserved TOR signaling (TOS) motif in the N-terminus of S6K1 that is required for its mTOR-dependent activation. Furthermore, our data suggested that the TOS motif suppresses an inhibitory function associated with the C-terminus of S6K1. Here, we characterize the mTOR-regulated inhibitory region within the C-terminus. We have identified a conserved C-terminal RSPRR sequence that is responsible for an mTOR-dependent suppression of S6K1 activation. Deletion or mutations within this RSPRR motif partially rescue the kinase activity of the S6K1 TOS motif mutant (S6K1-F5A) and this rescued activity is rapamycin-resistant. Furthermore, we show that the RSPRR motif significantly suppresses S6K1 phosphorylation at two phosphorylation sites (Thr389 and Thr229) that are crucial for S6K1 activation. Importantly, introducing both the Thr389 phospho-mimetic and RSPRR motif mutations into the catalytically inactive S6K1-F5A S6K1 mutant completely rescues its activity and renders it fully rapamycin resistant. This data shows that the N-terminal TOS motif suppresses an inhibitory function mediated by the C-terminal RSPRR motif. We propose that the RSPRR motif interacts with a negative regulator of S6K1 that is normally suppressed by mTOR.
J. Biol. Chem, 10.1074/jbc.M413995200
Submitted on December 13, 2004
Revised on January 18, 2005
Accepted on January 19, 2005
Characterization of a conserved C-terminal (RSPRR) motif in S6K1 required for its mTOR-dependent regulation
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
U. Narayanan, V. Nalavadi, M. Nakamoto, G. Thomas, S. Ceman, G. J. Bassell, and S. T. Warren S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade J. Biol. Chem., July 4, 2008; 283(27): 18478 - 18482. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hou, L. He, and R. Z. Qi Regulation of S6 Kinase 1 Activation by Phosphorylation at Ser-411 J. Biol. Chem., March 9, 2007; 282(10): 6922 - 6928. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Williamson, D. R. Bolster, S. R. Kimball, and L. S. Jefferson Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR. Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E80 - E89. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Chen, D. C. Chan, C. Donald, M. B. Lilly, and A. S. Kraft Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells Mol. Cancer Res., August 1, 2005; 3(8): 443 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Holz and J. Blenis Identification of S6 Kinase 1 as a Novel Mammalian Target of Rapamycin (mTOR)-phosphorylating Kinase J. Biol. Chem., July 15, 2005; 280(28): 26089 - 26093. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |